Skip to main content
FinSpry Logo
FinSpry
LUCD logo
LUCD
(NASDAQ)
Lucid Diagnostics Inc.
$1.14-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Lucid Diagnostics (LUCD) Stock Price & Financial Analysis

Lucid Diagnostics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.12 - $1.16
52-Week High$1.80
52-Week Low$0.95
Open$1.12
Volume298.97K
Average Volume (3M)298.97K
Market Cap123.32M
Shares Outstanding108.18M
Price to Sales (P/S)28.28
Price to Book (P/B)4.82
EV/EBITDA-1.92
Revenue (TTM)4.40M
Net Income (TTM)-53.28M
Free Cash Flow (TTM)-44.18M
EPS (TTM)$-0.49
Profit Margin-1211.30%
Operating Margin-1091.27%
Return on Equity (ROE)-206.25%
Debt to Equity0.91
50-Day MA$1.29
200-Day MA$1.16
52-Week Change-19.01%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Lucid Diagnostics

What is the current stock price for LUCD?

As of the latest trading session, LUCD stock trades at $1.14. The 52-week range is $0.95–$1.80, with a day range of $1.12–$1.16.

What is the P/E ratio for LUCD?

The P/E ratio (Price-to-Earnings) for LUCD is shown in the Key Statistics section. This valuation metric helps compare Lucid Diagnostics Inc. to industry peers.

Does LUCD pay dividends?

Lucid Diagnostics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for LUCD?

Based on 2 analysts, the consensus for LUCD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of LUCD?

Lucid Diagnostics's market capitalization is $123.3M, classifying it as a micro-cap company. Lucid Diagnostics operates in the Healthcare sector within the Medical Devices industry.